Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
CH1251125998
Wed, 03.06.2026
MindMaze Therapeutics Holding SA
MindMaze Therapeutics Holding SA
/ Key word(s): AGMEGM
MindMaze Therapeutics Publishes Invitation to the 2026 Annual General Meeting
03.06.2026 / 06:45 CET/CEST
MindMaze Therapeutics Publishes Invitation to the 2026 Annual General Meeting
Geneva, Switzerland – June 3, 2026 – MindMaze Therapeutics Holding SA (SIX: MMTX) [ … ]
Tue, 26.05.2026
MindMaze Therapeutics Holding SA
MindMaze Therapeutics Announces CHF 8.0 Million Strategic Equity Financing
Geneva, Switzerland – May 26, 2026 – MindMaze Therapeutics Holding SA (SIX: MMTX) (MindMaze Therapeutics or the Company), a global leader in scalable precision neurotherapeutics, today announced it has entered into a definitive agreement for a CHF 8.0 million equity financi [ … ]
Tue, 12.05.2026
MindMaze Therapeutics Holding SA
MindMaze Therapeutics and Vibra Healthcare Sign Definitive Channel Partnership Agreement to Scale Advanced Neurotherapeutics Across the U.S.Vibra to Support Expansion of MindMaze Therapeutics’ Neurorehabilitation Platform across Leading U.S. Health Systems
Geneva, Switzerland and Mechanicsburg, Pennsylvania – May 12, 2026 – MindMaze Therapeutics [ … ]
Thu, 30.04.2026
MindMaze Therapeutics Holding SA
MindMaze Therapeutics Holding SA
/ Key word(s): Partnership
MindMaze Therapeutics and Vibra Healthcare Announce Go-to-Market Partnership to Expand Commercial Footprint of Precision Neurotherapeutics in the U.S.
30.04.2026 / 07:00 CET/CEST
MindMaze Therapeutics and Vibra Healthcare Announce Go-to-Market Partnership to E [ … ]
Wed, 15.04.2026
MindMaze Therapeutics Holding SA
MindMaze Therapeutics Publishes 2025 Annual Report and Corporate Update
Positive real-world evidence results from multi-site program conducted with Vibra Healthcare
Established clinical and commercial foundation in neurological care
Advancement of U.S. commercial expansion and reimbursement strategy
Appointment of Zach Henderson as Chief Execut [ … ]
Thu, 12.03.2026
MindMaze Therapeutics Holding SA
MindMaze Therapeutics Appoints HealthTech Veteran Zach Henderson as CEO to Accelerate Global Commercial Scale
Former Rune Labs and Glooko executive to lead MindMaze’s next phase of growth, focusing on U.S. market expansion and the delivery of scalable, AI-driven neurorestorative care.
Geneva, Switzerland – March 12, 2026 – MindMaze Therapeutics H [ … ]
